Jon P. Stonehouse, President & CEO at BIOCRYST PHARMACEUTICALS INC (BCRX), bought 30,000 shares at $5.55 ($167K) on 2024-05-13, disclosed to the SEC on 2024-05-15.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| BCRX | SELL | 2022-12-02 | $4.9M | — | Filing → |
| BCRX | SELL | 2022-01-13 | $2.8M | — | Filing → |
| BCRX | SELL | 2020-12-17 | $2.2M | — | Filing → |